Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Precancerous Conditions 3Breast Neoplasms 3Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Adenomatous Polyposis Coli 2Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Pathologic Complete Response 1Pancreatic Intraductal Neoplasms 1Pain 1Melanoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hypertension 1Desmoid Tumors 1Carcinoma, Non-Small-Cell Lung 1

Interventions

nirogacestat 4Toremifene 2Specimen Handling 2Magnetic Resonance Spectroscopy 2X-Rays 1Vinblastine 1Taxes 1Tamoxifen 1Sunitinib 1Sulindac 1Radiotherapy 1Phantoms, Imaging 1Nivolumab 1Methotrexate 1Ipilimumab 1Imatinib Mesylate 1Hydroxyurea 1Cryosurgery 1CTLA-4 Antigen 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Desmoid Tumors × Sulindac × Clear all
NCT00068419 2020-02-19

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Children's Oncology Group

Phase 2 Completed
70 enrolled 11 charts
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡